Riskpilot← Back to searchSign inGet full accessOmniCuris Nordic AB
ABActiveOrg 5569409039Ekgatan 35Other non-specialised retail sale · NACE 4712Est. 20130 employees
Revenue 2025
SEK 0
EBITDA margin
—
-138% vs 2024
Equity ratio
80.3%
Financial strength
Net profit 2025
SEK -90K
-144% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -130K | -138% |
| Net profit | SEK -90K | -144% |
| Total assets | SEK 215K | -64% |
| Equity | SEK 173K | -34% |
| Employees | 0 | — |
Legal name
OmniCuris Nordic AB
Org number
5569409039
Legal form
Aktiebolag
NACE code
4712 · Other non-specialised retail sale
Founded
30 augusti 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva verksamhet inom sjukvård, vård- och omsorg samt estetik. Bolaget ska bedriva verksamhet inom import och export av sjukvårdsartiklar, sjukvårdsutrustning, sjukvårdsprodukter och medicintekniska produkter Bolaget ska bedriva konsultverksamhet inom olika sjukvårdsinsatser. Bolaget ska bedriva personaluthyrning, samt därmed förenlig verksamhet
Address
Ekgatan 35
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | 509 | 0 |
| Staff expenses | — | — | — | −59 | −75 |
| EBITDA | 0 | 0 | — | 346 | −130 |
| Depreciation & amort. | — | — | — | −5 | −39 |
| EBIT | 0 | 0 | 0 | 340 | −169 |
| Net financials | — | — | — | — | −1 |
| Profit before tax | 0 | 0 | 0 | 260 | −90 |
| Tax | — | — | — | −54 | — |
| Net profit | — | — | 0 | 207 | −90 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | — | — | 56 | 601 | 215 |
| Equity | — | — | 56 | 263 | 173 |
| Long-term debt | — | — | — | — | — |
| Short-term debt | — | — | — | 258 | 42 |
| Total debt | — | — | — | 258 | 42 |
EBITDA margin
-13016600.0%
This company
15.8%
Market median
-82383644% vs market
20212025
Equity ratio
80.3%
This company
38.2%
Market median
+110% vs market
20212025
Return on equity
-52.2%
This company
18.4%
Market median
-384% vs market
20212025
Net profit margin
-9015000.0%
This company
8.1%
Market median
-111296396% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-12-01 – 2025-11-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-11-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OmniCuris Nordic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Teresa Kryssberg | Deputy Board Member | 0 companies |
| Roman Krzyszton | Deputy Board Member | 0 companies |
| Camilla Sylvia Kryssberg | Board of Directors | 0 companies |